Evidence map›Paper›PMID 30410595›Full record

ArticleJournal of Cancer2018

Identifying a Novel Biomarker

Yaoyi Xiong, Lushun Yuan, Liang Chen, Yuan Zhu, Shanshan Zhang, Xuefeng Liu, Yu Xiao, Xinghuan Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yaoyi XiongDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Lushun YuanDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Liang ChenDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yuan ZhuDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Shanshan ZhangDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xuefeng LiuDepartment of Pathology, Lombardi Comprehensive Cancer Center, Georgetown University Medical School, Washington DC, USA.
Yu XiaoDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xinghuan WangDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wuhan University · CNZhongnan Hospital of Wuhan University · CNGeorgetown University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although it is well known that smoking is one of pathogenesis of clear cell renal cell carcinoma (ccRCC), the underlying molecular mechanism is still unclear. In our study, the microarray dataset GSE46699 is analyzed by weighted gene co-expression network analysis (WGCNA). Then we identify 15 co-expressed gene modules in which the lightcyan module (R

Indexed as

biomarkerclear cell renal cell carcinoma (ccRCC)smokingTOP2Aweighted gene co-expression network analysis (WGCNA)

Identifiers

PMID30410595
PMCPMC6218786
OpenAlexW2898518073

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.